Marion Bessin Liver Research Center, Department of Medicine and Division of Hepatology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Int J Biochem Cell Biol. 2011 Feb;43(2):198-213. doi: 10.1016/j.biocel.2010.01.013. Epub 2010 Jan 18.
In recent years, there has been substantial progress in transplanting cells into the liver with the ultimate goal of restoring liver mass and function in both inherited and acquired liver diseases. The basis for considering that this might be feasible is that the liver is a highly regenerative organ. After massive liver injury or surgical removal of two-thirds or more of the liver tissue, the organ can restore its mass with completely normal morphologic structure and function. It has also been found under highly selective conditions that transplanted hepatocytes can fully repopulate the liver and cure a metabolic disorder or deficiency state. Fetal liver cells can also substantially repopulate the normal liver, and it is hoped in the future that effective repopulation will be achievable with cultured cells or cell lines, pluripotent stem cells from other somatic tissues, embryonic stem cells, or induced pluripotent stem cells, which can now be generated in vitro by a variety of methods. The purpose of this review is to present the major systems that have been used for liver repopulation, the variables involved in obtaining successful repopulation and what has been achieved in these various systems to date with different cell types.
近年来,在将细胞移植到肝脏中以恢复遗传和获得性肝脏疾病的肝质量和功能方面取得了实质性进展。考虑到这可能是可行的,其基础是肝脏是一个高度再生的器官。在大量肝损伤或手术切除三分之二或更多的肝组织后,该器官可以恢复其具有完全正常形态结构和功能的质量。在高度选择性条件下,也发现移植的肝细胞可以完全再填充肝脏并治愈代谢紊乱或缺乏状态。胎儿肝细胞也可以大量再填充正常肝脏,未来有望通过培养细胞或细胞系、来自其他体细胞的多能干细胞、胚胎干细胞或诱导多能干细胞来实现有效的再填充,这些细胞现在可以通过多种方法在体外生成。本综述的目的是介绍已用于肝脏再填充的主要系统、获得成功再填充所涉及的变量以及迄今为止使用不同细胞类型在这些不同系统中取得的成就。